BioSpace News Archive

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, April 29, at 4:15 p.m. ET to discuss first quarter 2020 financial results and provide a general business update.

Chiasma, Inc., a clinical, late stage biopharmaceutical company focused on improving the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases, announced the appointment of Anand Varadan as Executive Vice President, Chief Commercial Officer.

Predictive Oncology (NASDAQ: POAI) today announced that it has entered into an Exchange Agreement relating to a $2.1 million promissory note of the Company with Dr. Carl Schwartz, the company’s Chief Executive Officer.

Incyte (Nasdaq:INCY) today announced that data from the Phase 3 REACH2 study have been published in The New England Journal of Medicine demonstrating that ruxolitinib (Jakafi®) improves outcomes across a range of efficacy measures in patients with steroid-refractory acute graft-versus-host disease (GVHD) compared to best available therapy (BAT).

Lexicon Pharmaceuticals, Inc. will release its first quarter 2020 financial results on Monday, April 27, 2020 before market opens.

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

Atara Biotherapeutics, Inc., a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, reported the grant of inducement awards to Amar Murugan, its Senior Vice President, General Counsel.

Vivera Pharmaceuticals, Inc., a California based pharmaceutical company has started nationwide delivery of its point of care, serological antibody rapid Covid-19 test kits.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted Janne Heimonen to Managing Director of International.

Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, today announced the launch of a clinical study using the company’s ground-breaking AI-based solution to remotely monitor the cardiac safety of COVID-19 patients during hydroxychloroquine treatment via analysis of electrocardiogram (ECG) data gathered from smartwatches